Cancer

Cancer is increasingly common in individuals under the age of 50. the death rate from cancer among people under the age of 40 also increased by a third. Every year, this disease catches more than a million in the 50s. not getting the world's population.

The path of the cancer disease in each patient and its treatment is unique. Sthe most diverse task of the medical sector is to .atfind and offer revolutionary solutions for interventional oncology: from ultra-precise ablation procedures performed with the help of artificial intelligence to radioembolization procedures.

Minimally invasive solutions in the treatment of oncological diseases help to preserve and preserve the health of patients and achieve optimal treatment results, recovery time after these interventions is significantly less. The future of interventional oncology is a partnership of progressive health care professionals and the constant introduction of innovative solutions. Innovation-based treatment solutions can change the practice of treating oncological diseases and shape the future of cancer treatment.

Cancer treatment solutions:

LIVER
CANCER

LUNG
CANCER

THYROID
CANCER

KIDNEY
CANCER

BREAST
CANCER

BONE
CANCER

PROSTATE
CANCER

SKIN
CANCER

COLON
CANCER

PAIN CAUSED BY CANCER

Let's get in touch

Do you have any questions or want to know more about our solutions? Write it and soon our expert will contact you.

Products

3

CAS-One IR

Artificial intelligence navigation system developed by Swiss manufacturer CASCINATION to help plan, navigate and remove tumours during percutaneous interventions

1

TATO

An attachment developed by Japanese manufacturer TERUMO that can use up to four antennas simultaneously. It is extremely easy to operate, ergonomic and ensures a safe procedure

2

CRYOCARE TOUCH

US company VARIAN's system is designed to freeze tissue at ultra-low temperatures, and the cryoprobe can produce "ice balls" of various sizes

4

CLINIPORATION VITAE

The IGEA system from IGEA, an Italian company, is an electrochemotherapy system that can be used for both superficial tumours and parenchymal tumours